Taragjini Christina, Schiro Brian, Bemd Bente A T van den, Pena Constantino S
Herbert Wertheim College of Medicine, Florida International University, Miami, Florida.
Department of Interventional Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, Florida.
Semin Intervent Radiol. 2025 Jan 28;41(6):576-580. doi: 10.1055/s-0044-1800848. eCollection 2024 Dec.
Endovascular aortic aneurysm repair (EVAR) has become the preferred treatment for abdominal aortic aneurysms, offering a minimally invasive alternative to open surgery. However, successful outcomes depend on meticulous patient selection. This review explores the key criteria for patient eligibility, including aneurysm size, morphology, and the quality of the proximal and distal aneurysm necks. Additionally, imaging assessment and various device variables, including anatomical suitability, are examined to emphasize their influence on procedural success. As EVAR technology evolves, understanding the nuances of patient selection remains crucial for maximizing technical success and clinical outcomes, while minimizing complications including endoleaks and migration, and extending the benefits of the procedure to a broader range of patients.
血管内主动脉瘤修复术(EVAR)已成为腹主动脉瘤的首选治疗方法,为开放手术提供了一种微创替代方案。然而,成功的治疗效果取决于精心的患者选择。本综述探讨了患者入选的关键标准,包括动脉瘤大小、形态以及近端和远端动脉瘤颈部的质量。此外,还对影像评估和各种器械变量(包括解剖学适宜性)进行了研究,以强调它们对手术成功的影响。随着EVAR技术的不断发展,了解患者选择的细微差别对于最大限度地提高技术成功率和临床疗效、同时将包括内漏和移位在内的并发症降至最低,并将该手术的益处扩展到更广泛的患者群体仍然至关重要。